New York, NY · Founded 2015 · Privately Held (backing)
Developer of a sequencing platform designed to make whole-genome sequencing fast, affordable, and actionable. Gencove is based in New York, NY and was founded in 2015. It was valued at $50 million at its later-stage round in Oct 2021, the last priced event on record. It has raised $16 million across 3 recorded rounds; the latest was a $9.8 million early-stage round in Oct 2021.
PMV mark · valuation
$50.0M
Oct 2026
Priced at
its later-stage round
Oct 2021
Total raised
$16.0M
Last round
Early Stage VC
Oct 2021
Cap table — not yet on record
Gencove's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gencove with a free account
·The complete investor list: 13 names
·Watch Gencove: the Monday email on marks, rounds and moves